Find Payment Partner
Find partners
Partners/United States/Galileo

Galileo

Tier 1Very high fitAML· Unverified
Galileo Financial Technologies
🇺🇸 United States·Money Transmitter·Regulated by ·galileo-ft.com

Banking-as-a-Service and payment processing platform.

Add to compareClaim profile

Overview

Banking-as-a-Service and payment processing platform.
Category: Banking-as-a-Service

Categories

Card IssuingEmbedded FinanceAPI
Source tags
baasembedded financecard issuingapi

Target customers

—

AI summary

Best for
Banking-as-a-Service
Typical clients
—
Strengths
  • Very high partnership fit signal
  • Tier 1 marketplace listing
  • Broad capability set: Card Issuing, Embedded Finance, API
Potential weaknesses
  • Public registration date not disclosed in source data
  • Coverage outside United States not confirmed in source data
Partnership opportunities
  • Card issuing programmes and BIN access
  • Embedded finance / platform partnership
AI summary is generated deterministically from imported public data. Verify any partnership claim directly with the provider before acting on it.

Licence information

Regulator—
Licence typeMoney Transmitter
Legal ID—
Registration dateNot disclosed
Country🇺🇸 United States

Trust & AML transparency

Reviewed by Andréas Hobbelin — Founder, Find Payment Partner — AML & Financial Crime Prevention expert
88/100
Unverified
Numeric AML score is free with your work email.
Full AML breakdown & signals
Included with the Professional plan.
See Professional
MVP scores are capped at the top of the Public Data band (59). Upper bands unlock when providers submit and verify documentation. Methodology.

Marketplace signal

MVP tierTier 1
Partnership fitVery high

Website

galileo-ft.com

Information is based on available regulatory, public, provider-submitted and Ai Risk Intelligence reviewed data where applicable. The platform does not provide legal advice, regulatory advice or guarantee partner acceptance. Users must perform their own due diligence before entering any partnership. AML scores reflect publicly available information and provider-submitted documentation; they are not an assessment of actual AML compliance or risk and do not constitute regulatory advice.